Fidia Spa (IT:FDA)
:FDA
Want to see IT:FDA full AI Analyst Report?
FDA Stock Chart & Stats
€0.12
>-€0.01(-6.28%)
At close: 4:00 PM EST
€0.12
>-€0.01(-6.28%)
Day’s Range― - ―
52-Week Range<€0.01 - €0.52
Previous CloseN/A
Volume4.67M
Average Volume (3M)597.93K
Market Cap
€12.74M
Enterprise Value-€362.93K
Total Cash (Recent Filing)€1.67M
Total Debt (Recent Filing)€1.23M
Price to Earnings (P/E)―
Beta0.81
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,249,412,000
10 Day Avg. Volume275,058
30 Day Avg. Volume597,935
Financial Highlights & Ratios
PEG Ratio-0.17
Price to Book (P/B)2.28
Price to Sales (P/S)0.60
P/FCF Ratio-4.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue ReboundA strong 2025 revenue rebound signals recovering end-market demand and renewed commercial traction. Sustained top-line growth provides scope for absorbing fixed costs, rebuilding margins and supporting reinvestment into R&D and commercial expansion if the trend persists over multiple quarters.
Improved Capital PositionReturn to positive equity and relatively modest reported debt improve solvency and strategic flexibility. A healthier capital base reduces immediate refinancing pressure, enabling management to prioritize operational fixes, targeted investments, or partnership funding without urgent balance-sheet restructuring.
Niche Product & Distribution ModelSpecialization in hyaluronic-acid therapies and a mix of direct sales and distributor partnerships create durable market coverage. Manufacturing plus partner-based geographic reach support recurring product demand, potential licensing revenue, and the ability to scale sales without proportionate fixed-cost increases.
Bears Say
Weak Cash GenerationPersistent negative operating and free cash flow signals ongoing cash burn, which can force reliance on external financing. Over months, weak cash generation constrains capex, R&D, and commercial investment, raises refinancing risk, and can impair the company’s ability to execute strategic initiatives.
Inconsistent ProfitabilityVolatile and generally negative operating profitability undermines durability of earnings and limits internal funding. Erratic margins complicate forecasting, reduce the cushion against demand shocks, and make it harder to demonstrate repeatable economics to partners or lenders over a multi-quarter horizon.
Leverage Volatility & Historic Solvency RiskPast episodes of high leverage and negative equity indicate balance-sheet sensitivity to earnings swings. This structural volatility increases refinancing and covenant risk, potentially limiting strategic options and elevating the cost of capital if cash generation does not stabilize.
Fidia Spa News
FDA FAQ
What was Fidia Spa’s price range in the past 12 months?
Fidia Spa lowest stock price was <€0.01 and its highest was €0.52 in the past 12 months.
What is Fidia Spa’s market cap?
Fidia Spa’s market cap is €12.74M.
When is Fidia Spa’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Fidia Spa’s earnings last quarter?
Currently, no data Available
Is Fidia Spa overvalued?
According to Wall Street analysts Fidia Spa’s price is currently Overvalued.
Does Fidia Spa pay dividends?
Fidia Spa pays a Annually dividend of €0.2 which represents an annual dividend yield of N/A. See more information on Fidia Spa dividends here
What is Fidia Spa’s EPS estimate?
Fidia Spa’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fidia Spa have?
Fidia Spa has 1,249,412,000 shares outstanding.
What happened to Fidia Spa’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Fidia Spa?
Currently, no hedge funds are holding shares in IT:FDA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Fidia Spa
Fidia S.p.A., together with its affiliated entities, focuses on engineering, producing, and supplying advanced high-speed milling systems and computerized numerical control (CNC) machines. Their product range also incorporates specialized milling heads, accompanying software, and various peripheral devices. Among these accessories, the HMS system is engineered for precise measurement and compensation of geometric errors in continuous or indexed bi-rotary heads and roto-tilting tables. The TMSC device accurately determines tool length and diameter, in addition to verifying its overall geometry. The K5 tracer provides a seamless solution for continuous scanning of three-dimensional surfaces. Other components include user-friendly pushbutton panels, XPower digital drives that control axis and spindle movement, and I/O Line input/output modules. Fidia's extensive software suite features ViMill, an anti-collision safeguard; HiMonitor, which tracks machine operational status; and Velocity 5, a system designed to optimize axis control, thereby enhancing machine performance. The HiMill computer-aided manufacturing (CAM) software is dedicated to the fabrication of dies, models, and aerospace components. An intuitive user interface is offered through the Isograph solution, while procedure-PRX provides tailored automation capabilities. The company serves critical sectors such as the automotive, aerospace, and power generation industries. Fidia's global presence covers Italy, the wider European continent, Asia, and both North and South America. Established in 1974, Fidia S.p.A. maintains its corporate headquarters in San Mauro Torinese, Italy.
Technical Analysis
Biesse SPA
―
Interpump Group SPA
―
Tesmec S.p.A.
―
Esautomotion SpA
―
Marzocchi Pompe S.p.A.
―